Margaret Marshall
Keine laufenden Positionen mehr
Profil
Margaret Marshall worked as a Director of Clinical Research & Oncology at Pfizer Inc. from 2004 to 2012.
She then worked as a Senior Director of Clinical Development at Kite Pharma, Inc. from 2012 to 2014.
From 2014 to 2018, she worked as a Senior Director of Clinical Research at Kyowa Kirin Pharmaceutical Development Ltd.
Currently, she is working as the Chief Medical Officer at Barinthus Biotherapeutics Plc, a position she started in 2020.
Dr. Marshall received her undergraduate degree from the California Institute of Technology and her doctorate degree from the University of California San Diego.
Ehemalige bekannte Positionen von Margaret Marshall
| Unternehmen | Position | Ende |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 20.07.2023 |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01.02.2018 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 01.09.2014 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01.10.2012 |
Ausbildung von Margaret Marshall
| California Institute of Technology | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Kyowa Kirin Pharmaceutical Development Ltd.
Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
